# BESREMi Pen

NDC: 73536-511
Generic name: ROPEGINTERFERON ALFA-2B
Labeler / Manufacturer: PharmaEssentia USA
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20260625

FDA application: BLA761166

## Active ingredients

- ROPEGINTERFERON ALFA-2B: 500 ug/.5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73536-511"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73536-511
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=9583405d-53a0-49dc-88eb-5e6384ebabcb